WealthSecure Pro 7-Year review

Yes, for accumulation-focused buyers who want a broad menu and do not need the income rider. The QuarterLock strategy and the Fidelity factor index options give this product more crediting variety than a basic FIA. If you also want the option to add a GLWB rider down the road without going through a new contract, the requirement to elect it at issue is a real consideration. If your main goal is income from day one, there are purpose-built income FIAs with lower entry costs.

The accumulation case here is the crediting menu. Most FIAs give you one or two S&P 500 strategies and a fixed account. WealthSecure Pro offers six indexed crediting methods across three indices, including the QuarterLock approach on two Fidelity factor indices. The low minimum premium of $2,000 also makes this accessible to buyers who would not qualify for FIAs with $10,000 or $25,000 minimums. And for buyers who want the flexibility to activate income later, the GLWB rider with an 8.50% compound rollup and a 5% benefit-base bonus is a legitimate add-on — provided they elect it at issue.

I think WealthSecure Pro 7-Year is best for someone in their early-to-mid 50s who wants to let money grow for seven or more years, likes having multiple crediting strategies to choose from, and wants the option — but not the obligation — to activate income later. The low minimum premium makes it accessible for buyers putting in smaller amounts alongside other retirement savings. It is less well-suited for someone who needs guaranteed lifetime income now, wants the simplicity of a single S&P 500 strategy, or cannot commit to a full 7-year lockup.

This is a principal-protected insurance contract, not a market investment. You give S.USA Life a premium, they credit interest based on formulas tied to index performance, and they guarantee you will not lose principal due to index declines. The indices involved — S&P 500, Fidelity U.S. Quality Factor 5% ER, and Fidelity Stocks for Inflation 5% ER — drive the crediting formulas, but you are not buying shares in those indices. The "5% ER" embedded in the Fidelity index names means there is a built-in volatility-control mechanism that reduces the index's measured volatility, which in turn allows the carrier to offer higher participation rates. That is worth understanding before you compare the 185% biennial participation rate on those indices to a simpler cap on the S&P 500 — they are measuring different things.

The QuarterLock strategy is the most distinctive element of this product. On both Fidelity indices, you can choose a 2-year or 5-year QuarterLock term. Instead of measuring index performance from the contract anniversary at the start of the term to the anniversary at the end of the term (as a standard point-to-point does), QuarterLock records the index value at each quarterly anniversary throughout the term and credits based on the highest of those quarterly values relative to the starting value. The participation rates as of the rate sheet are 90% for the 2-year QuarterLock and 150% for the 5-year QuarterLock on both Fidelity indices.

The practical implication is that the strategy can capture gains from mid-term market peaks that a standard endpoint measurement would miss. In a market that rises and then falls back to its starting level, a point-to-point would credit nothing; QuarterLock would credit the gain from the peak quarter. In a market that rises steadily, the endpoint measurement and QuarterLock may land similarly. Neither is consistently better — the value depends on how markets move during the actual term.

Beyond QuarterLock, the contract also offers the S&P 500 with a 5.25% annual cap or a 30% participation rate, Fidelity factor indices with a 105% annual participation rate, a biennial Fidelity strategy at 185% participation, an annual performance-triggered strategy at a 5.00% declared rate (credited when the index is flat or positive), and a fixed account at 3.20%. All rates are as of the September 2025 rate sheet and will change.

The optional GLWB rider — available as Base GLWB (1.10% fee) or Enhanced GLWB (1.20% fee) at the benefit base — adds meaningful income optionality for buyers who want it. The rollup is 8.50% compound annually on the greater of the Guaranteed Withdrawal Benefit Value or the Performance Withdrawal Benefit Value (which tracks 100% of credited interest), for up to 10 years. There is also a 5% benefit-base bonus applied at issue — but that bonus is purely for income calculation purposes and does not add to your contract accumulation value. The Enhanced GLWB adds a chronic illness doubling feature: if you are permanently impaired (2 of 6 ADLs, cognitive impairment, or nursing/LTC/hospice confinement), the maximum annual benefit doubles. That is a meaningful protection layer for buyers who are also concerned about long-term care costs. The rider must be elected at issue — there is no add-on option later.

The 7-year surrender schedule here starts at 9%, which is on the steeper side for this duration band — many 7-year FIAs open at 7% or 8%. That front-loading matters because if you need access to money in the first couple of years, the cost is high. By year 7, the charge is down to 3%, which is more typical. A market value adjustment (MVA) can also apply to surrenders above the free withdrawal amount during the charge period, meaning the penalty you face could be higher or lower than the stated surrender charge depending on interest rates at the time.

The free withdrawal provision is genuinely flexible: 10% of contract value is available each policy year starting immediately (not after year one), with no MVA on that amount. RMDs attributable to the contract are exempt from both the surrender charge and MVA. The contract also includes a Nursing Home/LTC Confinement Waiver (90 consecutive days of confinement after the contract date) and a Terminal Illness Waiver (life expectancy 12 months or less) that allow full or partial withdrawals without charge or MVA. Those are meaningful safeguards, but this is still a long-term commitment. Do not put money here that you might need in three years.

The base contract has no annual product fee, no M&E charge, and no administration charge. That is a clean cost structure for accumulation. The only visible ongoing fee is the GLWB rider: 1.10% annually of the benefit base for the Base GLWB, or 1.20% for the Enhanced GLWB (which includes the chronic illness doubling feature). Those fees are charged against the benefit base — which grows at 8.50% compound — not against the contract accumulation value, so the fee impact on actual cash value growth depends on how the two tracks diverge over time.

The structural tradeoffs are the same as any FIA. Caps and participation rates limit upside. The Fidelity indices with embedded 5% volatility controls allow higher nominal participation rates but measure a dampened version of index performance. The QuarterLock strategy benefits from mid-term peaks but uses lower participation rates than the biennial point-to-point alternative on the same indices. None of these is a flaw — they are simply the exchange you make for principal protection.

Legal Entity: S.USA Life Insurance Company, Inc.

Parent: Prosperity Life Group

AM Best Rating: A-

S.USA Life is a smaller carrier than the major national annuity writers, but an A- from AM Best is a legitimate financial strength indicator. Prosperity Life Group distributes through specialty channels including WealthVest, which focuses on accumulation-oriented products. If you are not already familiar with S.USA Life, that is worth noting — not as a red flag, but because carrier familiarity matters for some buyers.